Revolution Medicines, Inc. is 1.9x more valuable than NEUROCRINE BIOSCIENCES INC by market capitalization ($30.74 B vs $16.17 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NBIX | RVMD |
|---|---|---|
| Market cap | $16.17 B | $30.74 B |
| US-listed rank | #700 | #453 |
| Revenue (latest FY) | $2.86B | $0.00 |
| Net income (latest FY) | $478.60M | -$1.13B |
| Net margin | 16.7% | - |
| P/E (trailing FY) | 33.8 | - |
| SEC filings | 2,097 | 782 |
Revolution Medicines, Inc. is 1.9x more valuable than NEUROCRINE BIOSCIENCES INC by market capitalization ($30.74 B vs $16.17 B).
In their latest fiscal years, NEUROCRINE BIOSCIENCES INC reported $2.86B in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: NEUROCRINE BIOSCIENCES INC and Revolution Medicines, Inc., or browse the full rankings.